Latest Thailand News

Activeport Group Ltd reported steady Q2 FY26 revenue with new contracts starting to contribute and a 5% increase in annualised recurring revenue to $6.3 million. The company also reduced cash burn significantly and strengthened its cash position to support growth.

Kingsgate Consolidated has delivered a stellar December quarter, boosting cash reserves by 56% and maintaining robust production guidance for FY26 amid favourable gold and silver prices.

Horizon Oil reported an 18% rise in production and sales volumes in Q2 FY26, driven by its first full quarter of Thailand asset output. The company also maintained strong cashflow, paid a final FY25 dividend, and secured a long-term gas supply agreement in Australia’s Northern Territory.

First Graphene and UK manufacturer FP McCann have successfully produced the first batch of graphene-enhanced concrete roof tiles, marking a significant step toward low-carbon, high-performance construction materials in the UK housing sector.

ReNerve Limited has secured market approval for its NervAlign® Nerve Cuff in Malaysia, marking a key milestone in its Asia-Pacific expansion strategy. This approval follows earlier clearances in Hong Kong and Thailand, positioning the company to tap into a growing regional nerve repair market.

Horizon Oil has approved a strategic $1.5 million investment to install a booster compressor at its Nam Phong gas field in Thailand, aiming to increase production by at least 40% by mid-2026.

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.

Jayride Group Limited reports a reduced quarterly loss and secures fresh capital, yet faces ongoing uncertainty over its ability to continue as a going concern during its ASX reinstatement process.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.

Orthocell has achieved its first commercial sales of Remplir™ in Hong Kong, marking a pivotal step in its Asian growth strategy and expanding its footprint across key global markets.

JAYRIDE Group Limited has raised $935,000 through a share placement and convertible notes, signaling strong shareholder confidence as it advances toward ASX reinstatement and regional SaaS growth.

Paragon Care Limited is set to acquire Indonesian medical aesthetics leader Haju Medical for A$70 million, aiming to boost its footprint across Asia Pacific and accelerate growth in the aesthetics sector.